Clinical trial
Pemetrexed for Previously Treated Patients With Metastatic Gastric Cancer: a Prospective Phase II Study
NCT01953419 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pemetrexed for Previously Treated Patients With Metastatic Gastric Cancer: a Prospective Phase II Study
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- June 30, 2014
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer